Resection of Gallbladder Cancer, Including Surgical Staging
Executive Summary
Gallbladder cancer is the most prevalent malignancy of the biliary tract, characterized by a significant correlation with age and a higher incidence in women. Chronic inflammation from cholelithiasis is the primary risk factor, though other conditions such as porcelain gallbladder and specific bacterial infections also increase risk. The prognosis is heavily dependent on the achievement of a complete (R0) resection; patients with incomplete resections face a 5-year survival rate of less than 5%, whereas complete resections can result in survival rates as high as 100% for early-stage disease. Surgical intervention is indicated for stages T1–4, N0/1, and M0, provided there is no evidence of distant metastasis (M1) or extensive N2 lymph node involvement. This document details the clinical presentation, preoperative requirements, staging-based resection strategies, and the technical steps of the surgical procedure.
Clinical Overview and Epidemiology
Disease Prevalence and Risk Factors
Gallbladder cancer is most frequently observed in specific geographic regions, notably Chile and India. While it is the most common biliary tract malignancy, it is often discovered incidentally in approximately 1% of patients undergoing cholecystectomy for gallstones.
Key Risk Factors include:
Cholelithiasis: Chronic inflammation associated with gallstones; cancer develops in 0.3% to 3.0% of these patients.
Porcelain Gallbladder: Associated with carcinoma in 15% of patients.
Demographics: Risk increases with age; the disease is two to three times more common in women.
Other Factors: Cigarette smoking, chemical and drug exposures, gallbladder polyps, Salmonella bacterial infections, choledochal cysts, anomalous junctions of the pancreatobiliary ducts, and primary sclerosing cholangitis.
Natural History and Survival Rates
Prognosis is dictated by the completeness of the surgical resection and the pathological stage of the disease.
Presentation and Preoperative Preparation
Clinical Presentation
Patients may present with symptoms mimicking chronic cholecystitis, though many cases are identified through other means:
Incidental Finding: Pathologic discovery after cholecystectomy (0.3–1% of cases).
Surgical Discovery: Identification during surgery presumed to be for cholelithiasis.
Physical Signs: A mass in segment 4/5 associated with the gallbladder (sometimes misidentified as an abscess), chronic constant pain, or jaundice (present in one-third of patients).
Diagnostic Requirements
Clinical History: Assessment for biliary colic, pain, pruritus, weight loss, anorexia, and previous biliary surgeries.
Physical Examination: Evaluation for a right upper quadrant mass and jaundice.
Imaging Modalities:
Ultrasound and Contrast-enhanced CT (CT angiogram is preferred).
Magnetic resonance cholangiopancreatography (MRCP).
Percutaneous cholangiography (PTC) is preferred over ERCP if invasive cholangiography is necessary.
Evaluation Focus: Assessment of porcelain gallbladder, mass size, necrotic lymph nodes, arterial/portal venous involvement, adjacent organ involvement, and peritoneal metastasis.
Surgical Indications and Staging Strategies
Indications and Contraindications
Indications: Gallbladder cancer staged at T1–4, N0/1, and M0.
Relative Contraindications: Lymph node metastases to the N2 compartment; T4 gallbladder cancer.
Absolute Contraindications: Peritoneal carcinomatosis or distant metastases (M1).
Resection Strategy by Stage
The extent of the procedure is determined by whether the cancer was identified preoperatively or as an incidental finding post-cholecystectomy.
Preoperative Identification
T2/3, N0/1, M0: Radical cholecystectomy and lymph node dissection.
Unilateral Vascular Involvement: Extended lobectomy and lymph node dissection.
T4, N0/1, M0: Extended lobectomy, lymph node dissection, possible vascular resection/reconstruction, and potential adjacent organ resection.
N2 or M1: No curative surgery; possible palliation via biliary or gastric bypass.
Incidental Finding Post-Cholecystectomy
T1a (Negative margins/nodes): No further therapy.
T1b (Negative margins/nodes): Gallbladder bed resection (segments 4b and 5) and lymph node dissection.
Any T1 (Positive cystic duct margin): Gallbladder bed resection, resection of cystic duct or common bile duct to negative margins, and lymph node dissection.
T2/3/4, M0: Gallbladder bed resection (segments 4b and 5) or extended lobectomy for R0, common bile duct resection, lymph node dissection, and resection of laparoscopic port sites.
The Surgical Procedure: Step-by-Step
A radical cholecystectomy involves the resection of segments 4b and 5 of the liver. If the tumor bulk or vascular invasion requires it, an extended right lobectomy is performed.
Phase 1: Exploration and Staging
Incision: A right subcostal (hockey stick) incision is favored. In patients with previous cholecystectomy, the incision incorporates previous port sites.
Exploration: Inspection for port-site and peritoneal metastasis. Ultrasound evaluates the primary tumor’s relation to vascular structures and rules out distant liver metastases.
Lymph Node Staging: The highest peripancreatic lymph node is excised and sent for frozen section. If positive, radical resection is usually abandoned as it indicates incurable disease (N2).
Phase 2: Dissection and Resection
Regional Lymphadenectomy: Dissection of N1 lymph nodes in the hepatoduodenal ligament (No. 12) and common hepatic (No. 8) and celiac arteries (No. 9).
Bile Duct Resection: Often necessary to adequately excise nodal tissue in the porta hepatis. The common bile duct is divided above the pancreas.
Vascular Assessment: Skeletonization of the portal vein and hepatic artery. If the main portal vein is involved, resection and reconstruction are required.
Hepatic Duct Transection: The left hepatic duct is identified and transected at the base of the umbilical fissure.
Liver Resection: Resection of the gallbladder bed, including segments 4b and 5, while protecting portal veins and hepatic arteries under direct vision.
Phase 3: Reconstruction and Drainage
Biliary Reconstruction: Performance of a Roux-en-Y hepaticojejunostomy, typically using a 70-cm jejunal loop.
Portal Vein Reconstruction: If necessary, accomplished with running nonabsorbable sutures (e.g., 5-0 or 6-0 Prolene).
Drainage: Closed drains are placed in the right upper quadrant near the anastomosis. Nasogastric decompression is continued until bowel function returns.
Postoperative Management
Required Testing
Surveillance in intensive or intermediate care (for extended procedures).
Coagulation parameters and hemoglobin monitoring for at least 72 hours.
Liver function tests and electrolytes (including phosphorus) for at least 72 hours.
Bilirubin level measurement on drain fluid if a bile leak is suspected.
Potential Complications
General: Pleural effusion, pneumonia, deep vein thrombosis (DVT), and pulmonary embolism.
Abdominal: Intra-abdominal bleeding, infected collections/abscess, liver failure (in extended procedures), bile leak/biloma, leakage of biliodigestive anastomosis, and portal vein thrombosis.
Surgical Insights and Technical Pearls
Laparoscopic Staging: Warranted for radiologic T3 or T4 cancers due to the high incidence of peritoneal metastases.
Vascular Scrutiny: Preoperative scans must be scrutinized for right hepatic arterial involvement if the tumor is in the gallbladder neck. If the artery is encased, an extended lobectomy is mandatory for resection.
Anatomical Variations: Accessory or replaced left hepatic arteries often pass across the lesser omentum; these should be preserved even if the porta hepatis is extensively involved.
Biliary Management: Stay sutures should be placed before dividing the intrahepatic bile duct to prevent the duct from retracting into the liver parenchyma.
Lymphorrhea Prevention: All lymphatic vessels encountered during dissection should be tied to prevent postoperative complications.
